コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 feasible and does not alter practices during CABG surgery.
2 ) undergoing isolated primary or reoperative CABG surgery.
3 and clinical outcomes of patients undergoing CABG surgery.
4 es morbidity in diabetic patients undergoing CABG surgery.
5 cularization prior to or in conjunction with CABG surgery.
6 PCI, 93% were recommended for PCI and 5% for CABG surgery.
7 idity and mortality compared to conventional CABG surgery.
8 orship was stratified by age and concomitant CABG surgery.
9 04) immediately before and for 30 days after CABG surgery.
10 endations of the 2004 ACC/AHA guidelines for CABG surgery.
11 death or MI in high-risk patients undergoing CABG surgery.
12 ssociated with atherogenic progression after CABG surgery.
13 pendent predictors of count discrepancies in CABG surgery.
14 reased risk of long-term mortality following CABG surgery.
15 e basis of significant predictors of type of CABG surgery.
16 ient mechanism to ensure quality of care for CABG surgery.
17 cTnI release in patients undergoing on-pump CABG surgery.
18 and 1.51 (95% CI, 1.03, 2.21) for same-stay CABG surgery.
19 and 1.55 (95% CI, 1.10, 2.18) for same-stay CABG surgery.
20 ality, readmission, and cardiac events after CABG surgery.
21 patients with mild to moderate AS requiring CABG surgery.
22 New-onset atrial fibrillation after CABG surgery.
23 s than patients without diabetes who undergo CABG surgery.
24 re may not be an adequate quality metric for CABG surgery.
25 (32.3%) developed atrial fibrillation after CABG surgery.
26 entified based on the presence of claims for CABG surgery.
27 nondiabetic and diabetic patients undergoing CABG surgery.
28 mitted within 30 days for reasons related to CABG surgery.
29 discharge is an important adverse outcome of CABG surgery.
30 ssions within 30 days of discharge following CABG surgery.
31 ociated with declines in hospital volume for CABG surgery.
32 a questionable graft for patients undergoing CABG surgery.
33 t clinical conditions in patients undergoing CABG surgery.
34 ntly to racial disparities in outcomes after CABG surgery.
35 ived endoscopic vein-graft harvesting during CABG surgery.
36 due to lower cardiac events associated with CABG surgery.
37 er after PCI, whereas stroke is higher after CABG surgery.
38 Rates of coronary angiography, PCI, and CABG surgery.
39 ut acute coronary syndrome (ACS) or previous CABG surgery.
40 , which was discontinued 1 to 6 hours before CABG surgery.
41 outcomes in participants undergoing on-pump CABG surgery.
42 issions for all patients undergoing isolated CABG surgery.
43 omplication of coronary artery bypass graft (CABG) surgery.
44 utilized after coronary artery bypass graft (CABG) surgery.
45 o underwent coronary artery bypass grafting (CABG) surgery.
46 cclusion after coronary artery bypass graft (CABG) surgery.
47 rafts after coronary-artery bypass grafting (CABG) surgery.
48 nts undergoing coronary artery bypass graft (CABG) surgery.
49 ortality after coronary artery bypass graft (CABG) surgery.
50 ard conduit in coronary artery bypass graft (CABG) surgery.
51 olated primary coronary artery bypass graft (CABG) surgery.
52 procedure than coronary artery bypass graft (CABG) surgery.
53 outcomes after coronary artery bypass graft (CABG) surgery.
54 s than on-pump coronary artery bypass graft (CABG) surgery.
55 nts undergoing coronary artery bypass graft (CABG) surgery.
56 mortality for coronary artery bypass graft (CABG) surgery.
57 after elective coronary artery bypass graft (CABG) surgery.
58 after primary coronary artery bypass graft (CABG) surgery.
59 tion following coronary artery bypass graft (CABG) surgery.
60 n (PCI) versus coronary artery bypass graft (CABG) surgery.
61 recovery after coronary artery bypass graft (CABG) surgery.
62 ortality after coronary artery bypass graft (CABG) surgery.
63 than men after coronary artery bypass graft (CABG) surgery.
64 re (VGF) after coronary artery bypass graft (CABG) surgery.
65 y standard for coronary artery bypass graft (CABG) surgery.
66 undergoing coronary artery bypass grafting (CABG) surgery.
67 ntion (PCI) or coronary artery bypass graft (CABG) surgery.
68 sm (VTE) after coronary artery bypass graft (CABG) surgery.
69 ortality after coronary artery bypass graft (CABG) surgery.
70 ery (LITA) for coronary artery bypass graft (CABG) surgery.
71 7 to 0.90], coronary artery bypass grafting (CABG) surgery (14.5% for clopidogrel 16.2% for placebo;
72 , 9.0-10.6]; P < .001) but similar rates for CABG surgery (3.1 [95% CI, 2.8-3.5] vs 3.4 [95% CI, 3.1-
73 alone and with coronary artery bypass graft (CABG) surgery, 30-day and 1-year mortality, and 30-day r
74 hresholds (500 coronary artery bypass graft [CABG] surgeries, 30 abdominal aortic aneurysm [AAA] repa
75 dian sternotomy (13 889 patients) or on-pump CABG surgery (35 941 patients) between 2001 and 2004 wer
76 d only coronary artery bypass graft surgery (CABG) surgery, 37 had both valve and CABG surgery, and 4
78 ese 10 333 patients, 13% had indications for CABG surgery, 59% for PCI, and 17% for both CABG surgery
79 ump CABG surgery (9135 patients) and on-pump CABG surgery (59044 patients) with median sternotomy fro
80 al effusions in the patients undergoing only CABG surgery (63%) or CABG surgery plus valve surgery (6
82 explored for patients who underwent off-pump CABG surgery (9135 patients) and on-pump CABG surgery (5
83 ssociated with coronary artery bypass graft (CABG) surgery-a robust model of ischemia/reperfusion inj
84 termediate- to high-risk patients undergoing CABG surgery, acadesine did not reduce the composite of
85 nts undergoing coronary artery bypass graft (CABG) surgery according to use of 2 lysine analog antifi
86 th previous coronary artery bypass grafting (CABG) surgery achieved clinical benefit from intensive l
87 y bypass graft (CABG) surgery, and same-stay CABG surgery after adjustment for differences in patient
91 icant differences in major bleeding prior to CABG surgery, although minor bleeding episodes were nume
92 ks, 6 months, and annually for 5 years after CABG surgery among 3876 patients enrolled in a 62-center
93 were 1.65 (95% CI, 1.05, 2.60) for same-day CABG surgery and 1.55 (95% CI, 1.10, 2.18) for same-stay
94 d long-term mortality of patients undergoing CABG surgery and a general population comparison cohort.
95 p21 variant with mortality in patients after CABG surgery and its prognostic value to improve the Eur
96 or the risk ratios in patients who underwent CABG surgery and patients with colon cancer versus the g
99 or the patients who had indications for both CABG surgery and PCI, 93% were recommended for PCI and 5
101 the utilization of saphenous vein grafts for CABG surgery and provide an overview of the current prac
102 dentify and track all patients who underwent CABG surgery and received DES for isolated PLAD disease
103 iac tissue samples were collected during the CABG surgery and were analyzed by reverse transcriptase
104 ommon after coronary artery bypass grafting (CABG) surgery and account for a significant percentage o
105 ommonly follow coronary artery bypass graft (CABG) surgery and are associated with less positive clin
106 who underwent coronary artery bypass graft (CABG) surgery and for surveillance CT examinations in pa
107 ients after coronary artery bypass grafting (CABG) surgery and is covered by Medicare, but no previou
108 Advances in coronary artery bypass grafting (CABG) surgery and percutaneous coronary intervention (PC
109 fectiveness of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PC
111 ized trials of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PC
112 fectiveness of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PC
113 (ie, combined coronary artery bypass graft [CABG] surgery and valve repair or replacement surgery, t
114 merican College of Cardiology Guidelines for CABG Surgery" and translated them into 40 verifiable beh
115 lity, 2.07 (95% CI, 1.36, 3.15) for same-day CABG surgery, and 1.51 (95% CI, 1.03, 2.21) for same-sta
118 t its long-term outcomes relative to on-pump CABG surgery, and most studies have been very small.
120 , the respective odds of mortality, same-day CABG surgery, and same-stay CABG surgery were 5.92, 4.02
121 lity, same-day coronary artery bypass graft (CABG) surgery, and same-stay CABG surgery after adjustme
123 spine surgery; coronary artery bypass graft (CABG) surgery; and craniotomy at 8 centers between Janua
126 e basis of recommended volume thresholds for CABG surgery are outdated and not reflective of recent a
130 erm results of coronary artery bypass graft (CABG) surgery are known, but less is known about the lon
134 tudied 5,034 consecutive patients undergoing CABG surgery at a single institution from 1997 to 2007.
135 Two separate cohorts of patients undergoing CABG surgery at a single institution were examined, and
136 the occurrence of atrial fibrillation after CABG surgery based on an analysis of a large multicenter
138 35 394 Medicare patients undergoing isolated CABG surgery between 2003 and 2008 at 934 surgical cente
139 35,394 Medicare patients undergoing isolated CABG surgery between 2003 and 2008 at 934 surgical cente
141 urgery, type of valve operation, concomitant CABG surgery, body mass index, preoperative arrhythmias,
142 (CABG/AVR) in asymptomatic patients who need CABG surgery but have mild to moderate aortic stenosis (
143 assignment, smoking status, and years since CABG surgery, but not with clinical events (p trend = 0.
144 ne does occur in patients who have undergone CABG surgery, but the degree of this decline does not di
145 indicator for coronary artery bypass graft (CABG) surgery, but further research into analysis and po
147 to 364 days and 1 to 10 years, the isolated CABG surgery cohort had a slightly higher mortality rate
148 s without CKD, coronary artery bypass graft (CABG) surgery combined with optimal medical therapy (OMT
149 h status scores were moderately better after CABG surgery compared with PCI (difference in SAQ angina
151 th off-pump coronary artery bypass grafting (CABG) surgery compared with on-pump surgery particularly
152 outcomes with coronary artery bypass graft (CABG) surgery compared with percutaneous coronary interv
153 The published articles examining obesity and CABG surgery contain conflicting results about the role
154 ts who undergo coronary artery bypass graft (CABG) surgery, data are conflicting on whether the gains
156 e patients with normal renal function before CABG surgery developed severe renal insufficiency (229/8
157 Use of aprotinin among patients undergoing CABG surgery does not appear prudent because safer and l
159 nt CABG by surgeons who performed 50 or more CABG surgeries during the study period, and for whom inf
161 ion) in 3014 patients undergoing their first CABG surgery enrolled in the Project of Ex-vivo Vein Gra
163 f patients who had atrial fibrillation after CABG surgery experienced more than 1 episode of atrial f
164 n grafts - the most commonly used conduit in CABG surgery - fail in 40-50% of treated patients by 10
165 Eligibility criteria for the trial included CABG surgery for coronary artery disease with at least 2
166 and other variables in 3939 patients who had CABG surgery from 1973 to 1979 in the Emory University S
167 appear to be an equally safe alternative for CABG surgery, further randomized study is warranted.
168 s who received aprotinin alone on the day of CABG surgery had a higher mortality than patients who re
171 aft harvest in coronary artery bypass graft (CABG) surgery has recently been called into question.
172 arge creatinine increases (> or = 50%) after CABG surgery have a higher 90-day mortality compared wit
175 ons (PCIs) and coronary artery bypass graft (CABG) surgery have demonstrated similar survival but hav
176 c events after coronary artery bypass graft (CABG) surgery have had small sample sizes, short follow-
177 delirium after coronary artery bypass graft (CABG) surgery have higher long-term out-of-hospital mort
179 98-292] in 2008; P < .001) and the number of CABG surgery hospitals providing fewer than 100 CABG sur
180 istically less likely than whites to undergo CABG surgery in 21 of the 23 most rigorous studies that
181 EMI undergoing PPCI with or without previous CABG surgery in a large real-world, all-comer population
182 vs 191; P<.001) and more patients underwent CABG surgery in low-volume hospitals (<100 procedures an
185 without acute coronary syndrome or previous CABG surgery in New York in 2009 and 2010 were used to a
188 ements in the outcome of patients undergoing CABG surgery in the past decade, graft patency remains t
190 iated with all-cause mortality after primary CABG surgery in whites and significantly improves the pr
192 GS: Results of coronary artery bypass graft (CABG) surgery in octogenarians show a consistent pattern
193 compared with coronary artery bypass graft (CABG) surgery in patients with chronic kidney disease.
194 ntion (PCI) or coronary artery bypass graft (CABG) surgery in the "all-comers" SYNTAX (Synergy Betwee
196 PCI) versus coronary artery bypass grafting (CABG) surgery in the EXCEL (Evaluation of XIENCE versus
197 or to MED and coronary artery bypass graft (CABG) surgery in the Surgical Treatment for Ischemic Hea
198 ions following coronary artery bypass graft (CABG) surgery in the Veterans Health Administration (VHA
199 in the Nationwide Inpatient Sample providing CABG surgery increased by 12% (212 in 2001 vs 241 in 200
203 function after coronary artery bypass graft (CABG) surgery is a key risk factor for in-hospital morta
204 ermine whether coronary artery bypass graft (CABG) surgery is associated with an increased risk of st
205 ficiency after coronary artery bypass graft (CABG) surgery is associated with increased short-term an
206 ours following coronary artery bypass graft (CABG) surgery is associated with worse prognosis, but a
212 kers had been measured within 24 hours after CABG surgery, key baseline covariates, and mortality wer
214 termediate- to high-risk patients undergoing CABG surgery, MC-1 did not reduce the composite of cardi
220 ath or MI in 2746 patients who had undergone CABG surgery only but was associated with a statisticall
223 rgoing on-pump coronary artery bypass graft (CABG) surgery or combined CABG/valve surgeries at a US c
224 s treated with coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI
225 on with either coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI
226 ularization by coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI
227 nts undergoing coronary artery bypass graft (CABG) surgery or percutaneous coronary interventions (PC
228 ath, nonfatal myocardial infarction, stroke, CABG surgery, or angioplasty among 1,314 participants in
229 eriority of coronary artery bypass grafting (CABG) surgery over percutaneous coronary intervention (P
232 ve, observational study of 846 white primary CABG surgery patients, we genotyped rs10116277, the 9p21
233 60% to 7% for coronary artery bypass graft (CABG) surgery patients (p < 0.001), rebounding at five y
234 w York State was used to identify treatment (CABG surgery, PCI, medical treatment, or nothing) recomm
235 42 (95% confidence interval [CI], 1663-1825) CABG surgeries per million adults per year in 2001-2002
236 ear in 2001-2002 to 1081 (95% CI, 1032-1133) CABG surgeries per million adults per year in 2007-2008
237 G surgery hospitals providing fewer than 100 CABG surgeries per year increased from 23 (11%) in 2001
238 ng 2000 to 2003, there were 314,710 isolated CABG surgeries performed at 294 STS hospitals in CON sta
239 tion (PCI) and coronary artery bypass graft (CABG) surgery performed in New York for patients without
240 tients undergoing only CABG surgery (63%) or CABG surgery plus valve surgery (62%) was significantly
242 patients with diabetes and multivessel CAD, CABG surgery provided slightly better intermediate-term
248 injury during coronary artery bypass graft (CABG) surgery requiring cardiopulmonary bypass are assoc
249 rtery disease, coronary artery bypass graft (CABG) surgery resulted in lower rates of death and myoca
250 In cases of ULMD, multivessel CAD, or LVD, CABG surgery should be favored in patients with complex
251 patients with diabetes and multivessel CAD, CABG surgery should be recommended as standard therapy i
254 d States had better long-term survival after CABG surgery than after percutaneous coronary interventi
255 risk was higher in patients having isolated CABG surgery than in the general population, particularl
256 ations for PCI and fewer recommendations for CABG surgery than indicated in the American College of C
258 % higher risk-adjusted mortality rates after CABG surgery than white patients (odds ratio [OR], 1.33;
261 For a patient who had been treated with CABG surgery, the estimated reduction in lifetime radiat
265 ortality after coronary artery bypass graft (CABG) surgery, the impact of lesser degrees of renal imp
267 l and surgeon volume-mortality relations for CABG surgery through the use of a population-based clini
268 Restriction of volume-based referral for CABG surgery to high-risk patients has been suggested, a
269 tent and receiving a thienopyridine awaiting CABG surgery to receive either cangrelor or placebo afte
270 versus on-pump coronary artery bypass graft (CABG) surgery to ascertain the relative efficacy of the
272 een 2001 and 2008, a substantial decrease in CABG surgery utilization rates was observed, but PCI uti
274 rdiac Surgery Database, we examined isolated CABG surgery volume, operative mortality, and the compos
275 ON states have significantly higher hospital CABG surgery volumes but similar mortality compared with
278 diabetic (versus PTCA) patients, the RR for CABG surgery was 0.81 (95% CI 0.75 to 0.88, P<0.0001) fo
279 y adjusted mortality rate ratio for isolated CABG surgery was 13.51 (95% confidence interval [CI], 12
280 parison, the mean annual hospital volume for CABG surgery was 84% lower in states without certificate
281 nalyses were used to evaluate whether PCI or CABG surgery was associated with better PCS or MCS score
282 tality, same-day CABG surgery, and same-stay CABG surgery were 5.92, 4.02, and 3.92 times the odds fo
284 ality rates for Medicare patients undergoing CABG surgery were higher in states without certificate o
285 rger differences in 1-year outcomes favoring CABG surgery were observed in patients at high risk for
286 ith previous atrial fibrillation) undergoing CABG surgery were randomized to either AFP maintenance o
287 t 54 institutions, 2,698 patients undergoing CABG surgery were randomized to receive placebo (n = 1,3
289 outcomes after coronary artery bypass graft (CABG) surgery while controlling for both patient and hos
290 S/prior CABG, only 1% of patients undergoing CABG surgery who could be rated were found to be inappro
291 cohort study of patients undergoing primary CABG surgery with cardiopulmonary bypass (CPB) (n=1663)
292 102,470 patients undergoing primary isolated CABG surgery with cardiopulmonary bypass during calendar
293 termediate- to high-risk patients undergoing CABG surgery with cardiopulmonary bypass enrolled betwee
294 ndent of case mix, among patients undergoing CABG surgery with cardiopulmonary bypass in US hospitals
296 Of the original 2203 patients undergoing CABG surgery with or without cardiopulmonary bypass from
298 he outcomes of coronary artery bypass graft (CABG) surgery with percutaneous coronary interventions (
299 uly 2007, 366 consecutive patients underwent CABG surgery, with (n = 112) or without (n = 254) concom